KeMyth Biotech was established in July 2015 with a mission to transform research into industrial innovations. Over the years, we have expanded our focus beyond infectious diseases to address a broader range of health challenges. Our core projects include antibiotic testing and screening platforms, rapid diagnostic testing kits, new drug development, and beauty & wellness products, all developed through the expertise of our team and in collaboration with industry partners. By integrating cutting-edge research with practical applications, we are committed to improving healthcare and enhancing quality of life.
The development of new antibiotics is an urgent priority. Antibiotic research often utilizes clinical drug-resistant strains to evaluate antimicrobial efficacy. However, the resistance mechanisms of clinical strains are often highly complex, making it difficult to assess the effectiveness of antibiotics against specific resistance mechanisms.
To address this issue, our company has developed an innovative antibiotic testing and screening platform using genetic engineering technology (*2017, Journal of Antimicrobial Chemotherapy*, 72, 3302-3316).
KEMYTH cassette Klebsiella pneumoniae Serotype K1/K2 Antigen Test
Klebsiella pneumoniae is a pathogen that frequently causes both community-acquired and hospital-acquired infections. It can lead to bacteremia, liver abscesses, upper respiratory tract infections, meningitis, endophthalmitis, and urinary tract infections.
With a pharmaceutical research mindset and professional extraction techniques, we have developed a range of natural health products to support overall well-being. Explore our selection and purchase at Kemyth Shop (kemythshop.com).
